Using routinely collected clinical data to support Clinical Trials: a view from Scotland

Similar documents
Physical comorbidity with bipolar disorder: lessons from UK data

Sarah J. E. Barry 1 *, Eleanor Dinnett 2, Sharon Kean 1, Allan Gaw 3, Ian Ford 1. Abstract. Introduction

Following the health of half a million participants

The OPRAA Cohort. Emma Reynish

A bs tr ac t. n engl j med 357;15 october 11,

Health & Social Care Research Strategy

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Survey Scottish Diabetes. Survey Monitoring Group

Scottish Diabetes Survey 2012

HPV Immunisation Uptake Statistics for the Catch-up Programme

Annual Report. Public Health Screening Programmes TO 31 MARCH Extract: Chapter 3 : Planning for Bowel Screening Programme

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

rosuvastatin, 5mg, 10mg, 20mg, film-coated tablets (Crestor ) SMC No. (725/11) AstraZeneca UK Ltd.

Scottish Diabetes Survey

Dr Barry D Vallance. Where does palliative care for patients with heart failure fit into the Scottish agenda for heart disease

Lifetime clinical and economic benefits of statin-based LDL lowering in the 20-year Followup of the West of Scotland Coronary Prevention Study

Proposals for E.coli surveillance Informatics- proposal for the Infection. VRE molecular epidemiology AMR alerts HPA repatriation Rotavirus

UCC Library and UCC researchers have made this item openly available. Please let us know how this has helped you. Thanks!

Public Health in Scotland. Association of Directors of Public Health 29 th November 2006

Reshaping Care Pathways for Older People. Anne Hendry National Clinical Lead for Quality

C oronary heart disease (CHD) is a leading cause of morbidity

Project Brief. New Cancer Waiting Times. Data Quality Assurance Audit

Access to Male & Female Sterilisation

The impact of the HPV vaccine in Scotland.

Post MI LVSD Teach and Treat

Epidemiological notes Susan Vaughan

Nurturing knowledge creation:

The CARI Guidelines Caring for Australians with Renal Impairment. Cardiovascular Risk Factors

HPV Immunisation Statistics Scotland

APPENDIX B: LIST OF THE SELECTED SECONDARY STUDIES

Public Health Screening Programmes. Annual Report

Ethnic Data Collection Strategy and Methods in NHS Scotland. 21st March 2016 Drew Millard

Wednesday 23rd September HEAT TARGETS: NETWORK EVENT Fall and fracture prevention

Surveillance of Surgical Site Infection Annual Report For procedures carried out from: January December 2009

Impact of health behaviours and health interventions on demand for and cost of NHS services in the North of Scotland (including Tayside)

Summary of the Health Needs in Rugby Borough

Scottish Diabetes Survey

Scottish Clinical Coding Standards

A Process Evaluation of the Implementation of ASSIST in Scotland

2. Morbidity. Incidence

IMMUNISATION PROGRAMMES IN NHS GREATER GLASGOW AND CLYDE

Your heart attack procedure explained

Consultation on publication of new cancer waiting times statistics Summary Feedback Report

Copyright 2013 The Authors. Deposited on: 04 March 2014

Proof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease. Produced on behalf of NHS Wales and Welsh Government

Population Based KCIs Data for 2006

Upper GI Cancer Quality Performance Indicators

Public Health Observatories: An introduction to the London Health Observatory in England and recent developments in Alberta. Learning objectives

Should we treat everybody over 60 years with a statin? Comprehensive primary prevention in practice

National Surveillance System for Human Papillomavirus Infection and Related Disease in Scotland

Uses of the NIH Collaboratory Distributed Research Network

Patient Education, Diabetes Education, Structured Patient Education What does it all really mean to a person with Diabetes?

Embedding pragmatic trials within databases of electronic health records / disease registries Tjeerd van Staa

Health Protection Scotland

Delivering rehabilitation in the community

Summary of 2011/12 QOF indicator changes, points and thresholds

SUBJECT: HPV vaccination programme update

The General Practice Research Database (GPRD) Further Information for Patients

Annual Report. Public Health Screening Programmes TO 31 MARCH Extract: Chapter 8 : Diabetic Retinopathy Screening

World Leading Expertise in Use of Medical Records

Public Health Screening Programmes Annual Report 1 April 2013 to 31 March 2014

National Group for Volunteering in NHS Scotland

Primary 1 Body Mass Index (BMI) Statistics

10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice

SCHEDULE 2 THE SERVICES. A. Service Specifications

The links between physical health in mental health

Teenage Booster Immunisation Statistics

GOVERNING BODY REPORT

CGA/16/39 Understanding the implications of multimorbidity analysis of UK Biobank data. Barbara Nicholl, Frances Mair, Bhautesh Jani and Duncan Lee

Cancer and Data in the New NHS May Di Riley, Director Clinical Outcomes

What are we aiming for?

More honoured in the breach

National Group for Volunteering in NHS Scotland Minutes of the meeting held on Tuesday 29 August 2017 Scottish Health Services Centre, Edinburgh

Tackling inappropriate polypharmacy in NHS Scotland

Activity Report April 2013 March 2014

1 APRIL 2007 TO 31 MARCH

Progress in improving cancer services and outcomes in England. Report. Department of Health, NHS England and Public Health England

abcdefghijklmnopqrstu

LIST OF ABBREVIATIONS

Health Inequalities and Community Profiling in the Western Isles. Martin Malcolm, Head of Public Health Intelligence, NHS Western Isles

5.2 Main causes of death Brighton & Hove JSNA 2013

HPV Immunisation Statistics Scotland

Item No: 10. Meeting Date: Wednesday 20 th September Glasgow City Integration Joint Board. Alex MacKenzie, Chief Officer, Operations

Teenage Booster Immunisation Statistics Scotland

Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181)

What is the risk of venous thromboembolism (VTE) in patients treated by an Outpatient Parenteral Antimicrobial Therapy (OPAT) Service?

Surveillance of Surgical Site Infection Annual Report For procedures carried out from: January December 2010

SCOTTISH STROKE CARE AUDIT DATA COLLECTION QUICK NOTES

SPARRA Mental Disorder: Scottish Patients at Risk of Readmission and Admission (to psychiatric hospitals or units)

FOCUS: Fluoxetine Or Control Under Supervision. Gillian Mead and Martin Dennis Co-chief investigators, on behalf of the FOCUS team

Acute Heart Failure. Study protocol

Health protection Scotland. Travel and International Health. Summary of Yellow Fever Vaccination Centres

Dementia Benchmarking Indicators Definitions and Data Sources Manual

Scottish Branch BGS Autumn Meeting

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

The National perspective Public Health England s vision, mission and priorities

Dr Graham Kramer GP Montrose National Clinical Lead for Self Management & Health

The Hepatitis C Action Plan for Scotland: Draft Guidelines for Hepatitis C Care Networks

Cancer and pharmacoepidemiology in Finland. Information sources and research possibilities

Transcription:

Using routinely collected clinical data to support Clinical Trials: a view from Scotland Professor Colin McCowan Robertson Centre for Biostatistics and Glasgow Clinical Trials Unit

From birth to death

Joined up data for better decisions: Guiding Principles for Data Linkage http://www.scotland.gov.uk/publications/2012/11/ 9015 Electronic Data Research and Innovation Service (edris) Glasgow Safe Haven Lothian Safe Haven

National Scottish Datasets http://www.ndc.scot.nhs.uk/

National Scottish Datasets Vital statistics Administrative data Birth certificates Marriage certificates Death certificates Outpatient attendances (SMR00) Hospital admissions: acute (SMR01), psychiatric (SMR04) Maternity (SMR02) Primary care Prescribing Information System (PIS) Scottish Immunisation Recall System (SIRS) Child Health Systems Programme (CHSP): preschool, school Support Needs System Disease registries Cancer registrations (SMR06) Bowel screening system (BoSS) Scottish Renal Registry (SRR) Scottish Stillbirth & Infant Death Enquiry (SSIDE) Scottish Stroke Care Audit SCI-CHD SCI-Diabetes Population surveys Scottish Health Surveys (SHS) Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS) Growing Up in Scotland (GUS) Health Behaviour in Scottish Children (HBSC) Scottish Longitudinal Study (SLS)

Glasgow Safe Haven Collaboration with Greater Glasgow & Clyde Health Board Develop a virtual EHR for research for population of ~1.3 million Develop governance systems to allow access to data for approved projects for approved researchers Promote clinical research using routine data and facilitate research through collaboration with RCB statistics and IT group Develop national and international collaborations using Glasgow Safe Haven data

Current Datasets Datasets in Safe Haven SMR00 - Outpatient Attendance SMR01 Acute inpatient & Day Care SMR02 Maternity SMR04 Mental Health - CHI GG&C patient population (1.3 million) - GRO Births and deaths date for GG&C - eprescribing encashed prescriptions for Glasgow - GP (LES and Keep Well) 250 practices REC approval is to submit an amendment every time 6 new databases are added - Heart Failure locally held national Heart Failure database - Rheumatology local clinical database - SCI DC GGC population of national Diabetic database - SCI Store results for GGC - Parkinson local clinical database for Movement disorders - Weight Management - PsyCIS schizophrenia database - Clozapine database In discussion to extend health data to other Boards in NRS West Lanarkshire, A&A, D&G and Golden Jubilee

Scottish Health Informatics Programme

Creating safe settings and data security SHIP Blueprint highlights: Safe Projects Safe People Safe Data Safe Settings Safe Outputs

Safe Projects Ethics approved Caldicott Guardian approved Privacy Advisory committee approved Peer reviewed Safe People Accredited organisation Accredited researchers Information Governance Training

Safe Data Governance approvals from clinical dataset to research extract NHS Clinical dataset Body text Clinical Data NHS Safe Haven Uni Safe Haven dataset Approved research extract Caldicott / LPAC approval Data Access Committee / Data Controller approval

Safe Settings Thomas and Walport Data Sharing Review (2008): environments for population based research and statistical analysis in which the risk of identifying individuals is minimised

Safe Settings

Safe Outputs Disclosure Disclosure occurs when information released reveals the identity or information about a respondent not already in the public domain. Statistical Disclosure Control Assessing the risk of disclosure from a potential release and taking measures, if appropriate, to lower that risk by modifying the data, changing the design of the statistic, or a combination of these. (Office of National Statistics, 2006)

Epidemiology Identify patients with specific disease or taking a specific treatment Use hospitalisations and death data to build-up clinical histories and investigate outcomes Support other research methods Cross-sectoral linkage Act as sampling frame for qualitative studies Support clinical trials Support feasibility studies and patient recruitment Research Using Routinely Collected Data Passive follow-up of subjects : cheaper, maximises follow-up

Women with breast cancer using endocrine therapy were missing tablets Study: Linking prescribing records to hospital discharge, cancer registry, cancer clinic data and mortality records Results: Low adherence was associated with poorer survival (HR=1.20; 95% CI=1.03 1.40, P=0.019) Adherence to medication in women with breast cancer

Cancer Screening in Women in Glasgow Lower uptake of bowel screening in women than for breast or cervical screening Study: Link screening records and examine difference in characteristics for uptake. Invite women for interview to explain why they use other cancer screening services but not bowel National Awareness and Early Diagnosis Initiative (NAEDI)

WOSCOPS trial Landmark trial of statin use in patients with no previous CHD Study: Used hospital discharge and mortality records to identify endpoints for adjudication Results:31% relative risk reduction in nonfatal myocardial infarction or death from coronary heart disease Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W.,... & Packard, C. J. (1995). New England Journal of Medicine, 333(20), 1301-1308. Cost 20m

0 5 10 15 20 25 30 % WOSCOPS follow-up Fifteen year follow-up using record linkage Study: Use record linkage of trial data to hospital discharge, cancer registry, and mortality records Results: Cost: 15k CHD death or CHD event Placebo Pravastatin 0 2 4 6 8 10 12 14 16 Years since randomisation Long-term follow-up of the West of Scotland Coronary Prevention Study. Ford, I., Murray, H., Packard, C. J., Shepherd, J., Macfarlane, P. W., & Cobbe, S. M. (2007). New England Journal of Medicine, 357(15), 1477-1486.

Twenty year follow-up using record linkage WOSCOPS follow-up

WOSCOPS Adjudicated endpoints vs record linkage WOSCOPS cause of death Coronary Heart Disease Record Linkage cause of death CHD Other cardiac PLOS One: Barry et al (2013) Other vascular Other Total 96 1 1 2 100 Other cardiac 0 3 0 0 3 Other vascular 0 2 15 1 18 Other 0 0 0 117 117 Total 96 6 16 120 238

WOSCOPS Adjudicated endpoints vs record linkage Record Linkage events 1st Myocardial Infarction Subsequent MI Coronary Heart Disease Other Cardiovascular Disease Noncardiac Chest Pain Other Non- Match Total First WOSCOPS MI event 217 (81.0%) 1 (0.4%) 22 (8.2%) 3 (1.1%) 15 (5.6%) 2 (0.7%) 8 (3.0%) 268 Subsequent WOSCOPS event 4 (11.1%) 17 (47.2%) 12 (33.3%) 0 (0.0%) 2 (5.6%) 0 (0.0%) 1 (2.8%) 36 Total 221 (72.7%) 18 (5.9%) 34 (11.2%) 3 (1.0%) 17 (5.6%) 2 (0.6%) 9 (3.0%) 304 PLOS One: Barry et al (2013)

The EHR4CR Project Electronic Health Records for Clinical Research